Two Sigma Advisers’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-31,415
Closed -$827K 2224
2025
Q4
$827K Buy
+31,415
New +$685K ﹤0.01% 1583
2023
Q3
Sell
-13,200
Closed -$114K 2603
2023
Q2
$114K Buy
+13,200
New +$118K ﹤0.01% 2194
2022
Q3
Sell
-71,600
Closed -$379K 2759
2022
Q2
$379K Sell
71,600
-232,700
-76% -$1.41M ﹤0.01% 2041
2022
Q1
$1.99M Buy
304,300
+269,300
+769% +$2.4M 0.01% 1259
2021
Q4
$574K Sell
35,000
-60,400
-63% -$1.26M ﹤0.01% 1857
2021
Q3
$2.77M Sell
95,400
-43,100
-31% -$1.43M 0.01% 1079
2021
Q2
$4.8M Sell
138,500
-185,400
-57% -$5.88M 0.01% 879
2021
Q1
$10.2M Sell
323,900
-28,000
-8% -$1.14M 0.03% 567
2020
Q4
$16.6M Sell
351,900
-36,200
-9% -$1.68M 0.04% 397
2020
Q3
$18.1M Sell
388,100
-146,200
-27% -$5.02M 0.05% 345
2020
Q2
$19.3M Buy
534,300
+60,100
+13% +$2.21M 0.06% 336
2020
Q1
$16.8M Buy
474,200
+187,700
+66% +$7.68M 0.06% 323
2019
Q4
$13M Buy
286,500
+252,200
+735% +$9.16M 0.03% 504
2019
Q3
$851K Buy
34,300
+13,500
+65% +$338K ﹤0.01% 1505
2019
Q2
$458K Buy
+20,800
New +$382K ﹤0.01% 1848

Other funds holding ZYME

Two Sigma Advisers's ZYME Position: Q1 2026 in Review

Two Sigma Advisers sold out of Zymeworks (ZYME) in Q1 2026, closing a stake of 31,415 shares — an estimated $827K sold.

Two Sigma Advisers first reported a position in ZYME in Q2 2019 and held it in 15 quarters. The position peaked at $19.3M in Q2 2020. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Two Sigma Advisers reported no remaining Zymeworks position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 31,415 Zymeworks shares in Q1 2026, an estimated $827K.
  • Two Sigma Advisers first reported a position in Zymeworks in Q2 2019 and held it in 15 quarters.
  • Two Sigma Advisers's Zymeworks position peaked at $19.3M in Q2 2020.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.